IL6 and colorectal carcinoma: Additionally, increased ROS is related to diverse metabolic changes, such as increased inflammatory cytokines IL-6 and IFN-γ and insulin resistance [31], which may modify the immune response and inflammatory process involved in the process of CRC [32].